Morbilidad materna y neonatal por infección SARS-CoV-2
Keywords:
SARS-COV-2, COVID 19, Pregnancy, Newborn.Abstract
Objective: to carry out an updated bibliographic review focused on maternal and neonatal morbidity due to SARS-CoV-2 infection with the purpose of evaluating the severity that could occur in these risk groups. Methodology: this study consisted of a systematic review between December 2019 and September 2020 using platforms such as: PubMed, Scopus, Digital Library of the Complutense University of Madrid, Google Scholar and Scielo. The data were tabulated according to the recommendations of the PRISMA guide. Results: Of 116 pregnant women with a positive diagnosis for COVID 19, 91.3% had a favorable evolution without requiring intensive care; 8.62% presented severe pneumonia and mechanical respiratory assistance and none of them died. On the other hand, of 117 neonates, 93.2% had negative results for COVID-19 while 6.8% had positive results and there were three neonatal deaths not related to COVID-19. Conclusions: This indicates that SARS-CoV-2 does not generate greater susceptibility in obstetric patients or neonates and usually only manifests with mild to moderate symptoms.
References
García Salido A. Revisión narrativa sobre la respuesta inmunitaria frente a coronavirus: descripción general, aplicabilidad para SARS-COV-2 e implicaciones terapéuticas. An Pediatría. 2020;93(1):61–7.
Ruiz Manriquez J, León Lara X, Campos Murguía A, Solis Ortega A., Pérez González B, Uscanga L, et al. Conocimiento sobre la infección por SARS-CoV-2 de Gastroenterólogos y Endoscopistas de Latino América. Rev Gastroenterol México. 2020;85(3):288–94.
Peng X, Xu X, Li Y, Cheng L, Zhou X. Transmission routes of 2019-nCoV and controls in dental practice. Int J Oral Sci. 2020;1(0):1–4.
Schwartz D, Amareen B. Infections in Pregnancy With COVID-19 and Other Respiratory RNA Virus Diseases Are Rarely, If Ever, Transmitted to the Fetus. Arch Pathol Lab Med. 2020;144(8):920–8.
Urrútia G, Bonfill X. Declaración PRISMA: una propuesta para mejorar la publicación de revisiones sistemáticas y metaanálisis. Med Clin. 2010;135(11):507–11.
Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395(10226):809–15.
Schwartz D. An Analysis of 38 Pregnant Women With COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2. Arch Pathol Lab Med. 2020;144(7):799–805.
Zeng H, Xu C, Fan J, Tang Y, Deng Q, Zhang W, et al. Antibodies in Infants Born to Mothers With COVID-19 Pneumonia. JAMA [Internet]. 26 de marzo de 2020;323(18):1848-9. Disponible en: https://jamanetwork.com/journals/jama/fullarticle/2763854
Fan C, Lei D, Fang C, Li C, Wang M, Liu Y, et al. Perinatal Transmission of COVID-19 Associated SARS-CoV-2: Should We Worry? Clin Infect Dis [Internet]. 17 de marzo de 2020; Disponible en: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa226/5809260
Mascarenhas VHA, Caroci-Becker A, Venâncio KCMP, Baraldi NG, Durkin AC, Riesco MLG. COVID-19 and the production of knowledge regarding recommendations during pregnancy: a scoping review. Rev Lat Am Enfermagem [Internet]. 2020;28. Disponible en: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-11692020000100606&tlng=en
Li Y, Zhao R, Zheng S, Chen X, Wang J, Sheng X, et al. Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, China. Emerg Infect Dis [Internet]. junio de 2020;26(6):1335-6. Disponible en: http://wwwnc.cdc.gov/eid/article/26/6/20-0287_article.htm
Wisner KL, Sit DKY, McShea MC, Rizzo DM, Zoretich RA, Hughes CL, et al. Onset timing, thoughts of self-harm, and diagnoses in postpartum women with screen-positive depression findings. JAMA psychiatry. 2013;70(5):490-8.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 AVFT – Archivos Venezolanos de Farmacología y Terapéutica
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
